Oxymetholone Therapy of Fanconi Anemia Suppresses Osteopontin Transcription and Induces Hematopoietic Stem Cell Cycling

Androgens are widely used for treating Fanconi anemia (FA) and other human bone marrow failure syndromes, but their mode of action remains incompletely understood. Aged Fancd2(−/−) mice were used to assess the therapeutic efficacy of oxymetholone (OXM) and its mechanism of action. Eighteen-month-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qing-Shuo, Benedetti, Eric, Deater, Matthew, Schubert, Kathryn, Major, Angela, Pelz, Carl, Impey, Soren, Marquez-Loza, Laura, Rathbun, R. Keaney, Kato, Shigeaki, Bagby, Grover C., Grompe, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297866/
https://www.ncbi.nlm.nih.gov/pubmed/25434823
http://dx.doi.org/10.1016/j.stemcr.2014.10.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297866/
https://www.ncbi.nlm.nih.gov/pubmed/25434823
http://dx.doi.org/10.1016/j.stemcr.2014.10.014

Ejemplares similares